Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells
- PMID: 24762298
- DOI: 10.3109/08916934.2013.801462
Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells
Abstract
Epigenetic events play a central role in the priming, differentiation and subset determination of T lymphocytes. Through their influence on chromatin conformation and DNA-accessibility to transcription factors and RNA polymerases, epigenetic marks allow or prevent gene expression and control cellular functions including cytokine expression. CpG-DNA methylation and post-translational modifications to histone tails are the two most well accepted epigenetic mechanisms. The involvement of epigenetic mechanisms in the pathogenesis of systemic lupus erythematosus (SLE) has been suggested by the development of lupus-like symptoms by individuals who received procainamide or hydralazine treatment resulting in a reduction of CpG-DNA methylation. To date, a growing body of literature indicates that the deregulation of cytokine expression through epigenetic disturbances can result in altered immune responses and autoimmune reactions. Over the past decade, various global and regional epigenetic alterations have been reported in immune cells from patients with SLE and other autoimmune disorders. More recently, the molecular mechanisms that result in epigenetic disturbances have been addressed, and deregulated transcription factor networks have been demonstrated to mediate epigenetic alterations in B and T lymphocytes from SLE patients. A better understanding of the molecular events that contribute to epigenetic alterations and subsequent immune imbalance is essential for the establishment of disease biomarkers and identification of potential therapeutic targets.
Keywords: Autoimmune disease; SLE; chromatin; epigenetic; inflammation.
Similar articles
-
Epigenetic regulation of immune cells in systemic lupus erythematosus: insight from chromatin accessibility.Expert Opin Ther Targets. 2024 Jul;28(7):637-649. doi: 10.1080/14728222.2024.2375372. Epub 2024 Jul 2. Expert Opin Ther Targets. 2024. PMID: 38943564 Review.
-
Epigenetic dysregulation in systemic lupus erythematosus.Autoimmunity. 2014 Jun;47(4):215-9. doi: 10.3109/08916934.2013.844794. Epub 2013 Oct 16. Autoimmunity. 2014. PMID: 24128164 Review.
-
Epigenetic regulation and the pathogenesis of systemic lupus erythematosus.Transl Res. 2009 Jan;153(1):4-10. doi: 10.1016/j.trsl.2008.10.007. Epub 2008 Nov 14. Transl Res. 2009. PMID: 19100952 Review.
-
Mechanistic aspects of epigenetic dysregulation in SLE.Clin Immunol. 2018 Nov;196:3-11. doi: 10.1016/j.clim.2018.02.002. Epub 2018 Feb 6. Clin Immunol. 2018. PMID: 29425851 Review.
-
Epigenetics in SLE.Curr Rheumatol Rep. 2017 Sep;19(9):58. doi: 10.1007/s11926-017-0685-1. Curr Rheumatol Rep. 2017. PMID: 28752494 Free PMC article. Review.
Cited by
-
cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus.J Immunol. 2019 Dec 1;203(11):2807-2816. doi: 10.4049/jimmunol.1900760. Epub 2019 Oct 25. J Immunol. 2019. PMID: 31653682 Free PMC article.
-
The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)-a systematic review.Mol Cell Pediatr. 2017 Dec;4(1):7. doi: 10.1186/s40348-017-0073-y. Epub 2017 Jul 6. Mol Cell Pediatr. 2017. PMID: 28685269 Free PMC article. Review.
-
Global research hotspots and frontier trends of epigenetic modifications in autoimmune diseases: A bibliometric analysis from 2012 to 2022.Medicine (Baltimore). 2023 Sep 29;102(39):e35221. doi: 10.1097/MD.0000000000035221. Medicine (Baltimore). 2023. PMID: 37773838 Free PMC article. Review.
-
Daphnetin inhibits inflammation in the NZB/W F1 systemic lupus erythematosus murine model via inhibition of NF-κB activity.Exp Ther Med. 2017 Feb;13(2):455-460. doi: 10.3892/etm.2016.3971. Epub 2016 Dec 13. Exp Ther Med. 2017. PMID: 28352315 Free PMC article.
-
Systemic Lupus Erythematosus in Children and Young People.Curr Rheumatol Rep. 2021 Feb 10;23(3):20. doi: 10.1007/s11926-021-00985-0. Curr Rheumatol Rep. 2021. PMID: 33569643 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous